Abstract:Background: Among the many immunosuppressive cells in the tumor microenvironment, tumor-associated-macrophages (TAMs) are well known to contribute to tumor development. TAMs can be conditioned (polarized) to transition between classical M1-like macrophages, or alternatively to M2-like macrophages. Both are regulated by signaling molecules in the microenvironment. M1-like TAMs can secrete classic inflammatory cytokines that kill tumors by promoting tumor cell necrosis and immune cell infiltration into the tumor microenvironment. In contrast, M2-like TAMs exhibit powerful tumor-promoting functions, including degradation of tumor extracellular matrix, destruction of basement membrane, promotion of angiogenesis, and recruitment of immunosuppressor cells, all of which further promote tumor progression and distal metastasis. Therefore, remodeling the tumor microenvironment by reversing the TAM phenotype will be favorable for tumor therapy, especially immunotherapy.Methods: PLGA nanoparticles encapsulating baicalin and melanoma antigen Hgp peptide fragment 25-33 were fabricated using the ultrasonic double-emulsion technique. The nanoparticles were further loaded with CpG fragments and used conjugated M2pep and a-pep peptides on their surfaces to produce novel nano-complexes. The capability to target M2-like TAMs and anti-tumor immunotherapy effects of nano-complexes were evaluated by flow cytometry and confocal microscopy in vitro. We also investigated the survival and histopathology of murine melanoma models administrated with different nanocomplexes. Improvements in the tumor microenvironment for immune attack of melanoma-bearing mice were also assessed.Results: The nano-complexes were effectively ingested by M2-like TAMs in vitro and in vivo, and the acidic lysosomal environment triggered the disintegration of polydopamine from the nanoparticle surface, which resulted in the release of the payloads. The released CpG played an important role in transforming the M2-like TAMs into the M1-like phenotype that further secreted inflammatory cytokines. The reversal of TAM released cytokines and gradually suppressed tumor angiogenesis, permitting the remodeling of the tumor microenvironment. Moreover, the activated TAMs also presented antigen to T cells, which further stimulated the antitumor immune response that inhibited tumor metastasis. Activated T cells released cytokines, which stimulated NK cell infiltration and directly resulted in killing tumor cells. The baicalin released by M1-like TAMs also killed tumor cells.Conclusion: The nano-complexes facilitated baicalin, antigen, and immunostimulant delivery to M2-like TAMs, which polarized and reversed the M2-like TAM phenotype and remodeled the tumor microenvironment to allow killing of tumor cells.

Ferumoxytol-Beta-Glucan Inhibits Melanoma Growth Via Interacting With Dectin-1 To Polarize Macrophages Into M1 Phenotype

Anti-tumor Macrophages Activated by Ferumoxytol Combined or Surface-Functionalized with the TLR3 Agonist Poly (I : C) Promote Melanoma Regression.

Tremella fuciformis Polysaccharide Induces Apoptosis of B16 Melanoma Cells via Promoting the M1 Polarization of Macrophages

Dectin-1 Activation by a Natural Product Β-Glucan Converts Immunosuppressive Macrophages into an M1-like Phenotype.

Ferumoxytol and CpG Oligodeoxynucleotide 2395 Synergistically Enhance Antitumor Activity of Macrophages Against NSCLC with EGFR(L858R/T790M) Mutation

Chitosan-Poly(Acrylic Acid) Nanoparticles Loaded with R848 and MnCl2 Inhibit Melanoma Via Regulating Macrophage Polarization and Dendritic Cell Maturation.

Biomimetic inducer enabled dual ferroptosis of tumor and M2-type macrophages for enhanced tumor immunotherapy

Ferroptosis-Strengthened Metabolic and Inflammatory Regulation of Tumor-Associated Macrophages Provokes Potent Tumoricidal Activities

Codonopsis Pilosula Polysaccharide in Synergy with Dacarbazine Inhibits Mouse Melanoma by Repolarizing M2-like Tumor-Associated Macrophages into M1-like Tumor-Associated Macrophages

Fucoidan Inhibits CCL22 Production Through NF-κB Pathway in M2 Macrophages: a Potential Therapeutic Strategy for Cancer

Antagonism by Ganoderma Lucidum Polysaccharides Against the Suppression by Culture Supernatants of B16F10 Melanoma Cells on Macrophage.

Particulate Beta-Glucan Modulates Myeloid-Derived Suppressor Cells (MDSC) Activity in Tumor-Bearing Mice and Lung Cancer Patients (TUM4P.931)

Folate-modified Chitosan Nanoparticles Containing the IP-10 Gene Enhance Melanoma-specific Cytotoxic CD8(+)CD28(+) T Lymphocyte Responses

Inhibition of Tumor Growth by Β-Glucans Through Promoting CD4+ T Cell Immunomodulation and Neutrophil-Killing in Mice.

Dectin-1 Activation Subverts the Suppression of Myeloid-Derived Suppressor Cells by Inducing PMN-MDSC Apoptosis and Monocytic MDSC Differentiation to Potent Antigen-Presenting Cells in Cancer (TUM6P.961)

Correction: Yeast-Derived Particulate Β-Glucan Treatment Subverts the Suppression of Myeloid-Derived Suppressor Cells (MDSC) by Inducing Polymorphonuclear MDSC Apoptosis and Monocytic MDSC Differentiation to APC in Cancer.

Fucoidan, As an Immunostimulator Promotes M1 Macrophage Differentiation and Enhances the Chemotherapeutic Sensitivity of Capecitabine in Colon Cancer

Lactoferrin-containing Immunocomplex Mediates Antitumor Effects by Resetting Tumor-Associated Macrophages to M1 Phenotype.

In situ repolarization of Tumor-Associated Macrophages with synergic nanoformulation to reverse immunosuppressive TME in mouse breast cancer for cancer therapy

Tumor Microenvironment Remodeling And Tumor Therapy Based On M2-Like Tumor Associated Macrophage-Targeting Nano-Complexes

Polysaccharide isolated from Grifola frondosa eliminates myeloid-derived suppressor cells and inhibits tumor growth by enhancing T cells responses